The automated compounding devices market size has grown strongly in recent years. It will grow from $2.51 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing hospital pharmacy workload, rising demand for sterile iv preparation, early adoption of tpn compounding automation, hospital initiatives to reduce compounding errors, expansion of inpatient medication therapy volumes.
The automated compounding devices market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growing emphasis on medication safety compliance, rising investments in automated pharmacy technology, increasing outsourcing of sterile compounding services, expansion of oncology and critical care drug compounding, growing integration of digital workflow and reporting systems. Major trends in the forecast period include increasing adoption of automated compounding devices to reduce manual medication preparation errors in hospital and pharmacy settings, rising demand for high-precision compounding of iv formulations, oncology drugs, and tpn solutions, growing shift toward centralized and large-volume sterile compounding facilities in healthcare systems, expanding use of automated workflow validation and barcode-based verification in compounding processes, increasing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.
The growing prevalence of personalized medicines is expected to drive the expansion of the automated compounding devices market in the future. Personalized medicine involves tailoring healthcare decisions, practices, interventions, and treatments to the unique characteristics of each patient. This increase in personalized medicines is attributed to advances in genetics, patient-specific data, and regulatory support. Automated compounding devices (ACDs) are vital in personalized medicine, as they enable the precise and accurate preparation of custom medication formulations tailored to individual patient needs. These devices automate the process of mixing various pharmaceutical ingredients in exact proportions, which is essential for creating personalized treatments. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rise in personalized medicines is fueling the growth of the automated compounding devices market.
Major companies operating in the automated compounding devices market are emphasizing technological advancement through AI-powered robotic compounding solutions, including AI-enabled IV compounding platform systems that leverage artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high accuracy, real-time quality validation, and continuous supervision. For example, in August 2025, Omnicell, a U.S.-based health technology company, introduced an AI-driven upgrade to its IV compounding system aimed at enhancing safety and precision in medication preparation. The enhanced system incorporates sophisticated AI-based quality assurance capabilities that continuously oversee compounding processes and automatically identify and flag deviations from standard procedures. Through this advanced level of automated monitoring, Omnicell seeks to minimize human error, optimize workflow efficiency, and uphold elevated standards of medication quality within pharmacy operations.
In October 2024, Biovalley Investments & Partners S.p.A. (BIP), an Italy-based healthcare-focused industrial investment and pharma-automation company, entered into a partnership with Engmotion d.o.o. to jointly develop and industrialize the ChemoMaker automated IV chemotherapy compounding system. Through this collaboration, Biovalley and Engmotion seek to introduce a compact, hospital-ready hazardous IV compounding solution that automates the preparation of patient-specific chemotherapy doses within existing laminar flow hoods, enhancing accuracy, sterility, operator safety, and drug utilization while providing a more accessible alternative to large, high-cost IV robotic compounding systems. Engmotion d.o.o. is a Slovenia-based company specializing in high-precision automated filling and compounding systems for syringes, vials, cytostatics, and antibiotics used in medical and pharmaceutical applications.
Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc.
North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated compounding devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated compounding devices market by increasing the cost of precision pumps, electromechanical dispensing units, stainless-steel components, and electronic control modules sourced across international supply chains, leading to higher capital and maintenance costs for hospitals and ambulatory centers. The most affected segments include fully automated and tpn compounding systems in regions dependent on imported hardware assemblies, particularly in North America, Europe, and parts of Asia-Pacific. However, tariffs are also encouraging localized manufacturing, supplier diversification, and regional software-hardware integration initiatives, which may help reduce long-term dependency on foreign component sourcing.
The automated compounding devices market research report is one of a series of new reports that provides automated compounding devices market statistics, including automated compounding devices industry global market size, regional shares, competitors with a automated compounding devices market share, detailed automated compounding devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated compounding devices industry. This automated compounding devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated compounding devices are specialized pieces of equipment designed to automate the preparation of medications, including intravenous (IV) solutions, in healthcare settings. These devices ensure precise and efficient compounding, thereby enhancing patient safety and minimizing the risk of human error in medication preparation.
The main components of automated compounding devices include equipment and software. The equipment encompasses the physical parts of the devices used for automated medication preparation, such as robotic arms, dispensing units, and mixing chambers, which are crucial for the mechanical and physical operations that automate the compounding process, ensuring accuracy and efficiency. Product types are categorized into intravenous compounding systems, oral compounding systems, and total parenteral nutrition (TPN) compounding systems. The mode of operation includes fully automated and semi-automated compounding systems. End-users of these devices include hospitals, ambulatory surgical centers, and other healthcare facilities.
The automated compounding devices market consists of closed-system transfer devices, automated oral solid dose dispensers, and dispensing cabinets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated compounding devices market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growing emphasis on medication safety compliance, rising investments in automated pharmacy technology, increasing outsourcing of sterile compounding services, expansion of oncology and critical care drug compounding, growing integration of digital workflow and reporting systems. Major trends in the forecast period include increasing adoption of automated compounding devices to reduce manual medication preparation errors in hospital and pharmacy settings, rising demand for high-precision compounding of iv formulations, oncology drugs, and tpn solutions, growing shift toward centralized and large-volume sterile compounding facilities in healthcare systems, expanding use of automated workflow validation and barcode-based verification in compounding processes, increasing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.
The growing prevalence of personalized medicines is expected to drive the expansion of the automated compounding devices market in the future. Personalized medicine involves tailoring healthcare decisions, practices, interventions, and treatments to the unique characteristics of each patient. This increase in personalized medicines is attributed to advances in genetics, patient-specific data, and regulatory support. Automated compounding devices (ACDs) are vital in personalized medicine, as they enable the precise and accurate preparation of custom medication formulations tailored to individual patient needs. These devices automate the process of mixing various pharmaceutical ingredients in exact proportions, which is essential for creating personalized treatments. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rise in personalized medicines is fueling the growth of the automated compounding devices market.
Major companies operating in the automated compounding devices market are emphasizing technological advancement through AI-powered robotic compounding solutions, including AI-enabled IV compounding platform systems that leverage artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high accuracy, real-time quality validation, and continuous supervision. For example, in August 2025, Omnicell, a U.S.-based health technology company, introduced an AI-driven upgrade to its IV compounding system aimed at enhancing safety and precision in medication preparation. The enhanced system incorporates sophisticated AI-based quality assurance capabilities that continuously oversee compounding processes and automatically identify and flag deviations from standard procedures. Through this advanced level of automated monitoring, Omnicell seeks to minimize human error, optimize workflow efficiency, and uphold elevated standards of medication quality within pharmacy operations.
In October 2024, Biovalley Investments & Partners S.p.A. (BIP), an Italy-based healthcare-focused industrial investment and pharma-automation company, entered into a partnership with Engmotion d.o.o. to jointly develop and industrialize the ChemoMaker automated IV chemotherapy compounding system. Through this collaboration, Biovalley and Engmotion seek to introduce a compact, hospital-ready hazardous IV compounding solution that automates the preparation of patient-specific chemotherapy doses within existing laminar flow hoods, enhancing accuracy, sterility, operator safety, and drug utilization while providing a more accessible alternative to large, high-cost IV robotic compounding systems. Engmotion d.o.o. is a Slovenia-based company specializing in high-precision automated filling and compounding systems for syringes, vials, cytostatics, and antibiotics used in medical and pharmaceutical applications.
Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc.
North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated compounding devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated compounding devices market by increasing the cost of precision pumps, electromechanical dispensing units, stainless-steel components, and electronic control modules sourced across international supply chains, leading to higher capital and maintenance costs for hospitals and ambulatory centers. The most affected segments include fully automated and tpn compounding systems in regions dependent on imported hardware assemblies, particularly in North America, Europe, and parts of Asia-Pacific. However, tariffs are also encouraging localized manufacturing, supplier diversification, and regional software-hardware integration initiatives, which may help reduce long-term dependency on foreign component sourcing.
The automated compounding devices market research report is one of a series of new reports that provides automated compounding devices market statistics, including automated compounding devices industry global market size, regional shares, competitors with a automated compounding devices market share, detailed automated compounding devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated compounding devices industry. This automated compounding devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated compounding devices are specialized pieces of equipment designed to automate the preparation of medications, including intravenous (IV) solutions, in healthcare settings. These devices ensure precise and efficient compounding, thereby enhancing patient safety and minimizing the risk of human error in medication preparation.
The main components of automated compounding devices include equipment and software. The equipment encompasses the physical parts of the devices used for automated medication preparation, such as robotic arms, dispensing units, and mixing chambers, which are crucial for the mechanical and physical operations that automate the compounding process, ensuring accuracy and efficiency. Product types are categorized into intravenous compounding systems, oral compounding systems, and total parenteral nutrition (TPN) compounding systems. The mode of operation includes fully automated and semi-automated compounding systems. End-users of these devices include hospitals, ambulatory surgical centers, and other healthcare facilities.
The automated compounding devices market consists of closed-system transfer devices, automated oral solid dose dispensers, and dispensing cabinets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Compounding Devices Market Characteristics
3. Automated Compounding Devices Market Supply Chain Analysis
4. Global Automated Compounding Devices Market Trends and Strategies
5. Automated Compounding Devices Market Analysis of End Use Industries
7. Global Automated Compounding Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Compounding Devices Total Addressable Market (TAM) Analysis for the Market
9. Automated Compounding Devices Market Segmentation
10. Automated Compounding Devices Market Regional and Country Analysis
11. Asia-Pacific Automated Compounding Devices Market
12. China Automated Compounding Devices Market
13. India Automated Compounding Devices Market
14. Japan Automated Compounding Devices Market
15. Australia Automated Compounding Devices Market
16. Indonesia Automated Compounding Devices Market
17. South Korea Automated Compounding Devices Market
18. Taiwan Automated Compounding Devices Market
19. South East Asia Automated Compounding Devices Market
20. Western Europe Automated Compounding Devices Market
21. UK Automated Compounding Devices Market
22. Germany Automated Compounding Devices Market
23. France Automated Compounding Devices Market
24. Italy Automated Compounding Devices Market
25. Spain Automated Compounding Devices Market
26. Eastern Europe Automated Compounding Devices Market
27. Russia Automated Compounding Devices Market
28. North America Automated Compounding Devices Market
29. USA Automated Compounding Devices Market
30. Canada Automated Compounding Devices Market
31. South America Automated Compounding Devices Market
32. Brazil Automated Compounding Devices Market
33. Middle East Automated Compounding Devices Market
34. Africa Automated Compounding Devices Market
36. Automated Compounding Devices Market Competitive Landscape and Company Profiles
37. Automated Compounding Devices Market Other Major and Innovative Companies
40. Automated Compounding Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automated Compounding Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated compounding devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated compounding devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated compounding devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Automated Compounding Systems Equipment; Automated Compounding Systems Software2) By Product Type: Intravenous Compounding Systems; Oral Compounding Systems; Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems; Semi-Automated Compounding Systems
4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations; Compounding Pumps; Mixing Chambers; Scales And Balances; Dispensing Units; Vial And Syringe Filling Systems; Other Related Equipment (Filtration Devices)2) By Automated Compounding Systems Software: Prescription Management Software; Workflow Management Software; Monitoring And Control Software; Data Analytics And Reporting Software; Safety And Compliance Software; Integration Software For Hospital Or Pharmacy Management Systems
Companies Mentioned: Becton Dickinson and Company; Baxter International Inc; B Braun Melsungen AG; Fresenius Kabi AG; Terumo Corporation; ICU Medical Inc.; Omnicell Inc.; Tecan Group Ltd.; Fagron NV; Swisslog Healthcare; ScriptPro LLC; PharMEDium Services LLC; Loccioni Group SPA; ARxIUM Inc.; Codonics Inc.; Equashield LLC; Yuyama Mfg Co Ltd; Shanghai Weibond Technology Co Ltd; Medimpex LLC; Medica Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Compounding Devices market report include:- Becton Dickinson and Company
- Baxter International Inc
- B Braun Melsungen AG
- Fresenius Kabi AG
- Terumo Corporation
- ICU Medical Inc.
- Omnicell Inc.
- Tecan Group Ltd.
- Fagron NV
- Swisslog Healthcare
- ScriptPro LLC
- PharMEDium Services LLC
- Loccioni Group SPA
- ARxIUM Inc.
- Codonics Inc.
- Equashield LLC
- Yuyama Mfg Co Ltd
- Shanghai Weibond Technology Co Ltd
- Medimpex LLC
- Medica Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.69 Billion |
| Forecasted Market Value ( USD | $ 3.53 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
